February 21, 2025

FDA Approves First Cerebrotendinous Xanthomatosis Treatment

The FDA has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disorder.

Conexiant

February 21, 2025

CDC: Measles Cases Surge Amid Texas Outbreak

Measles cases in the U.S. surged from 14 to 93 in one week, with 95% of infections in unvaccinated or immunity-unknown individuals, per the CDC.

Reuters

February 20, 2025

NY Sues Major Vape Distributors Over Youth Marketing

Attorney General Letitia James files lawsuit against 13 e-cigarette companies for allegedly targeting minors with flavored nicotine products, seeking hundreds of millions in damages and penalties.

Conexiant

February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant

February 17, 2025

FDA Approves GSK’s 5-in-1 MenABCWY Vaccine

FDA approves GSK’s Penmenvy, a 5-in-1 meningococcal vaccine for adolescents and young adults, targeting five major serogroups of Neisseria meningitidis that cause invasive meningococcal disease.

Conexiant

February 17, 2025

FDA Approves Preparative Regimen for Allogeneic HSCT in Patients With AML or MDS

The FDA recently approved treosulfan (Grafapex), an alkylating agent, with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (HSCT) in adult and pediatric pat...

The ASCO Post

February 14, 2025

First Rapid-Acting Insulin Biosimilar Gets FDA Approval

FDA approves Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar to Novolog for glycemic control in adult and pediatric diabetes patients, expanding treatment accessibility.

Conexiant

February 13, 2025

Measles Outbreak in Texas: 24 Cases Reported

An outbreak of measles in Gaines County, Texas, has led to at least 24 reported cases, with none of the infected individuals being vaccinated, sparking concerns of potential further spread in the community.

Reuters

February 12, 2025

FDA Clears Rapid GI Test Panel for Gastroenteritis Detection

Clearance was granted to bioMérieux's BIOFIRE FILMARRAY GI Panel Mid, a 1-hour molecular test that can detect 11 common gastroenteritis-causing pathogens from a single stool sample.

Conexiant